Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON36697
NL-OMON36697
Completed
Phase 2

Prevention of the progression of very early symptoms into ankylosing spondylitis - PREVAS

Vrije Universiteit Medisch Centrum0 sites80 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsankylosing spondylitisspondyloarthritis10023213

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
ankylosing spondylitis
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
80
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients to be included must meet the following criteria.
  • •\- age \* 18 years,
  • •\- patient with inflammatory back pain for at least 3 months, with onset \< 45 years
  • •\- presence of ³2 SpA\-features or
  • •\- presence of ³1 SpA\-feature with HLA\-B27 positivity or two family members with definite AS (1e or 2e degree family\-member);
  • •\- no definite sacroiliitis on the X\-ray (sacroiliitis grade 1 is sustained);
  • •\- BASDAI score of \* 4 (0\-10\)
  • •\- Insufficient response to treatment with NSAID's over a 4\-week period

Exclusion Criteria

  • •\- definite AS (modified New York criteria (9\);
  • •\- previous treatment with TNF\-blockers.
  • •General medical exclusion criteria: for treatnebt with TNF blockers (pregnancy or planning pregnancy, infections, tuberculosis, HIV, Hepatitis B or C, malignincies etc)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
PREVENTION OF THE PROGRESSION OF VERY EARLY SYMPTOMSINTO ANKYLOSING SPONDYLITIS: A PLACEBO CONTROLLED TRIAL WITH ETANERCEPT - PREVAS
EUCTR2009-015515-40-NLWyeth Pharmaceuticals B.V.80
Not yet recruiting
Not Applicable
PREVAS: prevention of ankylosing spondylitis.ankylosing spondylitis, inflammatory back pain, morning stiffness, chronic (low) back pain, arthiritis, buttock pain, dactylitis, enthestitis, psoriasis, non-gonococcal urethritis or cercvicitis
NL-OMON29047investigator drive study supported by Wyeth80
Completed
Not Applicable
Prodromal symptoms and early intervention to prevent a relapse
ISRCTN17350364Mental Health Care Services Drenthe (Netherlands)147
Recruiting
Not Applicable
Pre-frail New efforts to prevent the progression of frail by intervention of agarooligosaccharides in the elderlyfrail
JPRN-UMIN000046285Matsumoo university30
Active, not recruiting
Not Applicable
Assessing the effectiveness of a mindfulness psychoeducation programme at preventing physical and psychological symptoms among cancer survivorsAlleviation of negative physical and psychological symptoms for cancer survivorsSigns and Symptoms
ISRCTN10756993ational University of Singapore210